BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35984655)

  • 21. Endovascular Extra-Anatomic Femoro-Popliteal Bypass for Limb Salvage in Chronic Critical Limb Ischemia.
    Di Primio M; Angelopoulos G; Lazareth I; Lin F; Petit A; Priollet P; Sapoval M; Emmerich J; Yannoutsos A
    Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1279-1292. PubMed ID: 31214761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contextualizing the BEST-CLI Trial Results in Clinical Practice.
    Butala NM; Chandra V; Beckman JA; Parikh SA; Lookstein R; Misra S; Secemsky EA
    J Soc Cardiovasc Angiogr Interv; 2023; 2(4):. PubMed ID: 37575528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative.
    Siracuse JJ; Menard MT; Eslami MH; Kalish JA; Robinson WP; Eberhardt RT; Hamburg NM; Farber A;
    J Vasc Surg; 2016 Apr; 63(4):958-65.e1. PubMed ID: 26830690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery.
    Kudo T; Chandra FA; Kwun WH; Haas BT; Ahn SS
    J Vasc Surg; 2006 Aug; 44(2):304-13. PubMed ID: 16890859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Affecting Mortality of Critical Limb Ischemia 1 Year after Endovascular Revascularization in Patients with Type 2 Diabetes Mellitus.
    Yunir E; Wisman BA; Antono D; Mansjoer A; Sarumpaet A; Iswati E; Rosana M; Tahapary DL; Tarigan TJE; Soewondo P
    Rev Diabet Stud; 2022 Mar; 18(1):20-26. PubMed ID: 35300753
    [No Abstract]   [Full Text] [Related]  

  • 26. Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice.
    Zarrintan S; Rahgozar S; Ross EG; Farber A; Menard MT; Conte MS; Malas MB
    J Vasc Surg; 2024 May; ():. PubMed ID: 38718850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical practice patterns and ascertainment bias for cardiovascular events in a randomized trial: A survey of investigators in the BEST-CLI trial.
    Albaghdadi MS; Young MN; Chowdhury MM; Assmann S; Hamza T; Siami S; Villarreal M; Strong M; Menard M; Farber A; Rosenfield K
    Vasc Med; 2021 Apr; 26(2):180-186. PubMed ID: 33825577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and use of healthcare resources after an intervention for chronic limb-threatening ischaemia.
    Saratzis A; Musto L; Kumar S; Wang J; Bojko L; Lillington J; Anyadi P; Zayed H
    BJS Open; 2023 Nov; 7(6):. PubMed ID: 37931235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes in the Management of Chronic Limb-Threatening Ischemia -- Analysis of the BEST-CLI Trial.
    Ramachandran M; Sen I; Tallarita T; Beckermann J; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2023 Apr; 37(4):632-636. PubMed ID: 36707379
    [No Abstract]   [Full Text] [Related]  

  • 30. Amputation After Endovascular Therapy With and Without Intravascular Ultrasound Guidance: A Nationwide Propensity Score-Matched Study.
    Setogawa N; Ohbe H; Matsui H; Yasunaga H
    Circ Cardiovasc Interv; 2023 Apr; 16(4):e012451. PubMed ID: 37071721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with lower preoperative quality of life in patients with chronic limb-threatening ischemia in the BEST-CLI trial.
    Powell RJ; Choudhry N; Conte M; Cziraky M; Giles K; Hamza T; Menard M; Rosenfeld K; Rowe V; Siracuse JJ; Strong M; Van Over M; Villarreal M; White C; Farber A
    J Vasc Surg; 2022 Dec; 76(6):1642-1650. PubMed ID: 35714891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization.
    Menard MT; Farber A; Powell RJ; Rosenfield K; Conte MS; Hamza TH; Kaufman JA; Cziraky MJ; Creager MA; Dake MD; Jaff MR; Reid D; Sopko G; White CJ; Strong MB; van Over M; Chisci E; Goodney PP; Gray B; Kayssi A; Siracuse JJ; Choudhry NK;
    Circulation; 2024 Apr; 149(16):1241-1253. PubMed ID: 38597097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of in-hospital deaths in patients with critical limb ischemia necessitating invasive treatments: based on a Japanese nationwide database.
    Iwata K; Nitta M; Kaneko M; Fushimi K; Ueda S; Shimizu S
    Cardiovasc Interv Ther; 2024 Apr; ():. PubMed ID: 38689203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging trends in nationwide mortality, limb loss, and resource utilization for critical limb ischemia in young adults.
    Uwumiro F; Okpujie V; Nebuwa C; Umoudoh U; Asobara E; Aniaku E; Makata G; Olukorode J
    Cardiovasc Revasc Med; 2024 Apr; ():. PubMed ID: 38616461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endovascular versus Surgical Lower Extremity Revascularization among Patients with Chronic Kidney Disease.
    Chen Q; Han J; Parvathinathan G; Ross E; Stedman MR; Chang TI
    Int J Nephrol; 2023; 2023():5586060. PubMed ID: 38144229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial and Ethnic Disparities in Treatment of Critical Limb Ischemia: A National Perspective.
    Wahood W; Duval S; Takahashi EA; Secemsky EA; Misra S
    J Am Heart Assoc; 2023 Sep; 12(17):e029074. PubMed ID: 37609984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of iloprost in patients with critical limb ischemia: Results of a cohort study from the COPART registry.
    Dari L; Constans J; Boulon C; Caradu C; Labépie FX; Bura-Rivière A; Chastaingt L; Lacroix P; Bezin J; Pariente A
    J Med Vasc; 2023; 48(5-6):163-173. PubMed ID: 38035922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial.
    Siracuse JJ; Menard MT; Rosenfield K; Conte MS; Powell R; Hamburg N; Doros G; Strong MB; Farber A
    J Vasc Surg; 2024 Apr; ():. PubMed ID: 38626847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of Major Amputations after Surgery Versus Endovascular Intervention: The BEST-CLI Randomised Trial.
    Venermo MA; Farber A; Schanzer A; Menard MT; Rosenfield K; Dosluoglu H; Goodney PP; Abou-Zamzam AM; Motaganahalli R; Doros G; Creager MA
    Eur J Vasc Endovasc Surg; 2024 Jun; ():. PubMed ID: 38925339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Limb-Threatening Ischemia and the Need for Revascularization.
    Berchiolli R; Bertagna G; Adami D; Canovaro F; Torri L; Troisi N
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.